Research Article

Factors Affecting the Self-Isolation Monitoring Program for COVID-19 Patients at the Universitas Indonesia Hospital

Table 3

Main symptoms and outcomes of COVID-19 self-isolation patients.

Outcome valueORCI
BetterWorse

Fever
Yes78 (39.60%)8 (4.10%)0.5930.7570.272–2.107
No103 (52.30%)8 (4.10%)

Cough
Yes146 (74.10%)15 (7.60%)0.1940.2780.036–2.177
No35 (17.80%)1 (0.50%)

Runny nose
Yes54 (27.40%)4 (2.00%)0.6841.2760.394–4.133
No127 (64.50%)12 (6.10%)

Shortness of breath
Yes22 (11.20%)7 (3.60%)0.0010.1780.060–0.526
No159 (80.70%)9 (4.60%)

Fatigue
Yes8 (4.10%)2 (1.00%)0.1580.3240.063–1.673
No173 (87.80%)14 (7.10%)

Anosmia
Yes65 (33.00%)4 (2.00%)0.381.6810.521–5.425
No116 (58.90%)12 (6.10%)

Headache
Yes45 (22.80%)2 (1.00%)0.2662.3160.507–10.584
No136 (69.00%)14 (7.10%)

Sore throat
Yes13 (6.60%)1 (0.50%)0.8891.1610.142–9.492
No168 (85.30%)15 (7.60%)

Nausea and vomiting
Yes39 (19.80%)6 (3.00%)0.1450.4580.157–1.338
No142 (72.10%)10 (5.10%)

Diarrhoea
Yes24 (12.20%)2 (1.00%)0.9311.070.229–5.004
No157 (79.70%)14 (7.10%)

Ageusia
Yes15 (7.60%)2 (1.00%)0.5650.6330.131–3.050
No166 (84.30%)14 (7.10%)

Chi-square.